share_log

HC Wainwright & Co. Reiterates Buy on Syndax Pharmaceuticals, Maintains $41 Price Target

HC Wainwright & Co. Reiterates Buy on Syndax Pharmaceuticals, Maintains $41 Price Target

HC Wainwright & Co.重申买入Syndax Pharmicals,维持41美元的目标股价
Benzinga ·  05/09 06:56

HC Wainwright & Co. analyst Edward White reiterates Syndax Pharmaceuticals (NASDAQ:SNDX) with a Buy and maintains $41 price target.

HC Wainwright & Co. 分析师爱德华·怀特重申Syndax Pharmicals(纳斯达克股票代码:SNDX)的买入并维持41美元的目标股价。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发